Rolf Stahel joins board at Connexios
This article was originally published in Scrip
Executive Summary
Rolf Stahel has been appointed non-executive chairman at Connexios Life Sciences (India), a drug discovery company discovering and developing new drugs for the treatment of metabolic diseases. Mr Stahel worked for 27 years at Wellcome in Switzerland, Italy, Thailand, Singapore and the UK, and also served as chief executive at Shire Pharmaceuticals for nine years.